3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Multiple Myeloma
5
Squamous Cell Carcinoma of Head and Neck
2
Peripheral Nervous System Diseases
2
Oropharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Vomiting
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Myasthenia Gravis
1
Mucositis
1
Lymphoma, Follicular
1
Lymphedema
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esthesioneuroblastoma, Olfactory
1
Interventions
fludarabine phosphate
31
Cyclophosphamide
27
Mycophenolic Acid
22
Whole-Body Irradiation
21
Tacrolimus
21
ruxolitinib
19
Peripheral Blood Stem Cell Transplantation
19
Busulfan
19
Antilymphocyte Serum
16
fludarabine
14
Melphalan
12
Methotrexate
11
Cyclosporine
10
thymoglobulin
9
Cord Blood Stem Cell Transplantation
7
Sirolimus
6
Radiotherapy
6
Etoposide
6
Azacitidine
6
Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporins
4
pomalidomide
3
parsaclisib
3
Surveys and Questionnaires
3
Rituximab
3
Prednisone
3
Filgrastim
3
Cytarabine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Primary Myelofibrosis
×
Acupuncture Therapy
×
Clear all
No trials found.